Silvia Pasini, PhD has a diverse work experience in the field of scientific research. In their current role as a Senior Scientist at Entrada Therapeutics, they apply their expertise to contribute to the company's projects.
Prior to this position, Silvia worked at Vedere Bio II, where they held the roles of Scientist II and Scientist. Silvia'sresponsibilities included various scientific research activities and projects.
Earlier in their career, Silvia worked at Vanderbilt University Medical Center as a Staff Scientist and Research Fellow. During this time, they simultaneously managed multiple projects, conducted behavioral assessments, and developed new in vitro models. Silvia also collaborated with lab members, supervised students, and organized monthly journal clubs.
Silvia's work experience also includes a role as a postdoctoral research scientist at Columbia University Medical Center. Here, they actively participated in research, acquired specialized skills, and collaborated with other principal investigators.
Overall, Silvia Pasini, PhD has a strong background in scientific research, with a focus on topics such as neural regeneration, glaucoma, and synaptic plasticity. Silvia'swork has resulted in publications in peer-reviewed journals and successful grant funding. Silvia has demonstrated excellent interpersonal and communication skills in supervisory roles and is experienced in research conception, design, and execution.
Silvia Pasini, PhD, obtained their education in the field of biotechnology and neuroscience. Silvia started their academic journey in 2003 at the University of Milano-Bicocca, where they pursued a Bachelor's degree in Biotechnology. Silvia graduated in 2006 and continued their studies at the same institution, obtaining a Master's degree in Medical Biotechnology from 2006 to 2008. Following this, Silvia Pasini furthered their academic pursuits by enrolling in the University of Milano-Bicocca's PhD program in Neuroscience. Silvia successfully completed their Doctor of Philosophy (Ph.D.) in Neuroscience from 2008 to 2011.
July 1, 2024 - present
May, 2023